Mumbai: A Parliamentary committee has uncovered a nexus between doctors, government bodies and pharmacy companies to approve new drugs without the mandatory clinical trials. The doctors from top hospitals wrote to the country's Drug Controller General, to allow new drugs to be marketed, without clinical trials - a shocking lapse, highlighted in this Parliamentary standing committee report. Drug expert CM Gulati said, "All of them are compromised. We've got the...
06:16 AM, May 14, 2012
Mumbai: After the Indian government recently lifted a patent license, Indian pharma major, Cipla, has announced a massive reduction of up to 76 per cent in its cancer drug prices. Following the move, the price of Cipla's generic kidney cancer drug, Sorafenib, will be available at Rs 6,840 a month from the earlier Rs 27,950. The lung cancer drug Gestinib price has been cut down by 60 per cent to...07:51 AM, May 05, 2012
Cipla, Ranbaxy, Hetero, Roche and Natco Pharma are in the race. ...12:37 AM, Aug 13, 2009
The Ambani groups have gained maximum benefit in stocks last week. ...03:07 PM, May 25, 2009
Kolkata: South African skipper Graeme Smith says his team has encountered vastly varying pitches in the cricket World Cup and the experience was likely to stretch on as they take on Bangladesh in the last group league game in Dhaka on Saturday. However, he sees no problem in adapting to the varying tracks. Referring to the Eden Gardens track on Tuesday night when his side crushed Ireland by 131 runs...11:13 PM, Jan 02, 2008
03:35 AM, Aug 22, 2007
The i-pill is showing contra-indications in Tamil Nadu. ...08:45 PM, Aug 21, 2007
Cipla has launched an HIV/AIDS drug that could be taken once a day by the patients for effective treatment. ...03:51 PM, Oct 13, 2006
displayed with permission. Use of the CNN name and/or logo on or as part of CNN-IBN does not derogate from the intellectual property rights of Cable News Network in respect of them.
Disclaimer: Network18 Media & Investments Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
Disclaimer: TV18 Broadcast Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
